Spectrum Pharmaceuticals, Inc. (SPPI): A Reacquired Drug Lottery Ticket
From Insider Monkey - Free Hedge Fund and Insider Trading Data
January 31, 2013 - 4:15pm
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) has worked some magic with acquisitions, driving sales of forgotten cancer drugs higher. Let’s see if it can do the same for its newest (re)acquisition. First, the biotech has to get the drug approved. The company announced today that it had reacquired the full rights to bladder cancer treatment apaziquone from its [...]
Continue reading this article »Share This Article: